Use of gfap for identification of intracerebral hemorrhage

Abstract

The present invention relates to the use of glial fibrillary acidic protein (GFAP) as a diagnostic marker for intracerebral hemorrhage. The invention especially relates to methods for the early detection of intracerebral hemorrhage. Such early and rapid detection can be performed rapidly e.g. by a test strip format assay. GFAP can be used as a stand-alone marker or in combination with one or more other markers.

What is claimed: 
     
         1 . A method of assessing the presence, absence or severity of intracerebral hemorrhage, said method comprising: analyzing a test sample obtained from a subject for the presence or amount of GFAP and correlating the presence or amount of GFAP in said sample to the presence, absence or severity of intracerebral hemorrhage.